Most of hematopoietic growth factors, including stem cell factor (SCF), interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colonystimulating factor (G-CSF), and erythropoietin (Epo), act as survival factors for hematopoietic progenitor cells. In their absence, hematopoietic progenitor cells succumb to apoptosis.'~' '
The regulation of cell death involves many mole~ules.'*~~~ Bcl-2 and its homologue, Bcl-x, which prolong cellular survival by inhibiting apoptosis, are expressed on hematopoietic progenitor cells, whereas terminally differentiated myeloid cells lack Bcl-2 and Bcl-x expressi~n.'~~'~ Furthermore, constitutive overexpression of Bcl-2 suppresses apoptosis of hematopoietic progenitor cells induced by the growth factor withdrawal.*'.*' Fas antigen (Fas Ag; CD9.5) is a cell surface molecule that can mediate apoptosi~.'~-'~ It has been reported that terminally differentiated myeloid cells such as neutrophils and monocytes constitutively expressed Fas Ag.I9 However, CD34+ hematopoietic progenitor cells have not been shown to express Fas Ag.22,23 These facts suggest that hematopoietic progenitor cells become positive for Fas Ag and lose Bcl-2 expression along with their differentiation. In the present study, we investigated the expression of Fas Ag and Bcl-2 on CD34' hematopoietic progenitor cells expanded in vitro in the presence of hematopoietic growth factors.
MATERIALS AND METHODS
Preparation of bone marrow (BM) CD34+ cells. BM was obtained by stemal aspiration from normal adult volunteers. Informed consent was obtained in all cases. BM was aspirated into syringes that contained preservative-free heparin. CD34+ cells were isolated from BM mononuclear cells by using CD34-conjugated immunoexpressed Bcl-2. CD34+ cells cultured with hematopoietic growth factors gradually became positive for Fas Ag and rapidly lost Bcl-2 expression. Furthermore, apoptosis was induced in the cultured CD34' population when anti-Fas antibody (IgM; 1 pg/mL) was added, as shown by significant decrease in the number of viable cells, morphologic changes, induction of DNA fragmentation, and significant decrease in the number of clonogenic progenitor cells including CFU-GM and BFU-E. These results indicate that functional expression of Fas Ag is induced on CD34' cells expanded in vitro in the presence of hematopoietic growth factors. Induction of Fas Ag and downregulation of Bcl-2 may be expressed as part of the differentiation program of hematopoietic cells and may be involved in the regulation of hematopoiesis.
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magnetic beads (Dynabeads M-450 CD34; Dynal, Oslo, Norway), as previously described.*' Immunomagnetic depletion of T and B cells was performed with CD2-and CD19-conjugated immunomagnetic beads (Dynabeads M-450 Pan T and Pan B; Dynal) to further purify the CD34' cells. The final purity of the CD34+ cells was greater than 95% when analyzed by flow cytometer (data not shown).
Monoclonal antibodies (MoAbs). Phycoerythrin (PE)-conjugated anti-CD34 MoAb (HPCA-2; IgGl) was purchased from Becton Dickinson (Mountain View, CA). Anti-Fas MoAb (CH-11; IgMK), which induces apoptosis by binding to Fas Ag, and fluorescein isothiocyanate (FITC)-conjugated anti-Fas MoAb (UB2; IgGl), which does not induce apoptosis, were purchased from Medical & Biological Laboratories Co (Nagoya, Japan). FITC-conjugated antiBcl-2 protein MoAb (124; IgG1) was purchased from DAKO (Copenhagen, Denmark). FITC-and PE-conjugated isotype-matched control IgGl were purchased from Becton Dickinson and isotypematched control IgM (TEPC 183) was purchased from Sigma Chemical (St Louis, MO).
Flow cytometric analysis of Fas Ag expression was performed as described below. The cells were washed with phosphate-buffered saline (PBS) containing 0.1 % sodium azide (binding buffer) and incubated with the binding buffer containing 1 mg/mL of y-globulin (Sigma Chemical) on ice for 15 minutes to block nonspecific binding. The cells were then incubated Recombinant human SCF, IL-3, IL-6, GM-CSF, G-CSF, and Epo were all kindly provided by Grin Brewery Co (Tokyo, Japan).
The isolated CD34' cells were cultured in 1 mL of culture medium consisting of Iscove's modified Dulbecco's medium (IMDM; GIBCO, Grand Island, NY) supplemented with 10% fetal calf serum (FCS; ICN Biomedicals, Costa Mesa, CA), 1 .O% deionized bovine serum albumin (Cohn fraction V; Sigma Chemical), 50 ng/mL SCF, 50 ng/mL IL-3, 50 ng/mL IL-6, 100 ng/mL G-CSF, and 3 U/mL Epo. Cells were plated at a density of 1 x IO4 cellslwell in 24-well plates (Falcon; Becton Dickinson Labware). The cultures were maintained in a humidified atmosphere with 5% C 0 2 in air at 37°C for 7 days. The cultured cells were harvested at days 1, 2, 3, and 5. Viable cells as detemiined by trypan blue dye exclusion were counted and the number of clonogenic progenitor cells was assayed. To determine whether the induced Fas Ag can mediate apoptosis in response to anti-Fas MoAb (IgM) treatment, we added anti-Fas MoAb or isotype-matched control IgM (TEPC 183) to the culture at different time of culture period. Results described below were generated using 1 pg/mL anti-Fas MoAb or control Ab, because the maximum antiFas MoAb-mediated cytocidal effect was observed at the concentration of 1 pg/mL (data not shown). After 12 hours of incubation, viable cells were counted, the number of clonogenic progenitor cells was assayed, and DNA fragmentation was evaluated by DNA ladder formation. The morphology of cultured cells spun on a cytocentrifuge slide (Cytospin 3; Shandon Southern Instruments, Sewickley, PA) was examined after May-Griinwald-Giemsa staining. Flow cytometric analysis was performed at days 2, 3, 5, and 7.
Clonogenic progenitor assays were performed by the methylcellulose culture method as previously described with minor modifications.2s Briefly, 1 X IO3 freshly isolated CD34' cells and 3 X lo3 cultured CD34' cells were inoculated in IMDM containing 0.88% methylcellulose, 30% FCS, 50 ng/mL SCF, 50 ng/mL IL-3, 10 ng/mL IL-6, 10 ng/mL GM-CSF, 10 ng/ mL G-CSF, 3 U/mL Epo, and 5 X lo-' molL 2-mercaptoethanol. Aliquots of 1 mL were plated in triplicate in 35-mm culture dishes (Falcon; Becton Dickinson Labware) at 37°C in a humidified atmosphere with 5% C 0 2 and 5% 0 2 . After 14 days of culture, colonyforming unit of granulocytes/macrophages (CFU-GM) and burstforming unit of erythroids (BFU-E) were counted under an inverted microscope.
Reverse transcriptase-polymerase chain reaction (RT-PCR).
RNA was prepared from 1 x lo" freshly isolated CD34' cells and 1 x IO4 cultured cells by the acid guani&ne/phenoUchloroform method.2b RT-PCR was performed as previously described.22 Thirty cycles of PCR with denaturation at 93°C for 1 minute, annealing at 65°C for 1 minute, and extension at 73°C for 1 minute were performed on a programmed-temperature system (PC-700; Astec, Fukuoka, Japan). PCR samples were electrophoresed on an ethidium bromide-stained 1.5% agarose gel. Primer sequences were as follows:
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5'-ATGCTGGGCATCTGGACC CTCCTA-3' and 5'-TCTGCA-CTTGGTATTCTGGGTCCG-3' for amplification of Fas mRNA, 1227 and 5'-GCACTCTTCCAGCCmCCTG-3' and 5'-GGAGTACTT-GCGCTCAG GAGGAGC-3' for amplification of /?-actin mRNA.2X DNA fragmentation of cultured cells was assessed by electrophoresis in agarose gel. Cell pellets (1 X 10' cells) were lysed in 0.5 mL of a buffer containing 5 mmoVL Tris-HC1 (pH 7.4). 5 mmoVL EDTA, and 0.5% Triton-X. Samples were extracted with phenol-chloroform and precipitated with ethanol. After air-drying, DNA was dissolved in 8 pL of 10 mmolL Tris-HC1 (pH 7.4), 1 mmoK EDTA, 1% sodium dodecyl sulfate and electrophoresed in an ethidium bromide-stained 1.5% agarose gel at 80 V for 3 hours.
Data were analyzed with the two-tailed Student's t-test. A P value <.05 was accepted as statistically significant.
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RESULTS
Expansion of isolated CD34' cells. CD34+ cells were cultured in media containing SCF, IL-3, IL-6, G-CSF, and Epo for up to 7 days. The number of cells continued to increase during the culture period. The mean cellular expansion at day 5 of culture was 30.6-fold. In the primary clonogenic progenitor assay of freshly isolated CD34+ cells, the mean numbers of CFU-GM and BFU-E were 30.6 ? 3.7 and 40.1 t 8.2 per 1 X 10' cells, respectively. The mean expansions of the clonogenic progenitor cells at day 5 were 6.9-fold and 8.8-fold for CFU-GM and BFU-E, respectively.
Both flow cytometric analysis and RT-PCR did not detect expression of Fas Ag or Fas mRNA in freshly isolated CD34' cells ( Figs  1 and 2) . However, CD34' cells cultured in the presence of hematopoietic growth factors showed induction of Fas expression (Figs 1 and 2 ). The expression of Fas Ag was rapidly induced on the CD34' cell population. Whereas CD34 expression on cultured cells was gradually downregulated, the expression of Fas Ag on cultured cells was upregulated during the culture period. The CD34+ cell population that expressed Fas Ag gradually lost CD34 expression and shifted to a CD34-Fas Ag' cell population. Approximately 90% of cultured cells lost CD34 expression and more than 95% of both CD34 cells and residual CD34' cells expressed Fas Ag at day 7. When CD34' cells were cultured in medium alone for 5 days, some slight expression of Fas Ag was observed (data not shown).
Flow cytometric analysis showed that approximately half of freshly isolated CD34' cells (59% ? 7.3%) expressed Bcl-2 (Fig 3) . A population of CD34'Bcl-2' cells was rapidly diminished when cultured in the presence of hematopoietic growth factors. Bcl-2 expression was downregulated during the culture period. Almost all of the cultured cells (>95%) lacked expression of Bcl-2 at day 7.
We tested whether the induced Fas Ag could mediate apoptosis in response to the agonistic anti-Fas MoAb. We added antiFas MoAb or isotype-matched control Ab (1 pg/mL) to the cultures at different time of culture period and assessed the number of viable cells, their morphologic characteristics, their DNA fragmentation, and the number of clonogenic progenitor cells after 12 hours of incubation. The addition nuclear fragmentation were increased in proportion after the addition of anti-Fas MoAb. Low molecular weight DNA extracted from these cells showed a pattern of DNA fragmentation, which is characteristics of apoptosis (Fig 6) . Furthermore, triggering of Fas Ag on cultured CD34' cells by antiFas MoAb could result in inhibition in their ability to form in vitro colonies with the clonogenic progenitor assays. The number of clonogenic progenitor cells, including both CFU-GM and BFU-E, significantly decreased after 12 hours of incubation with anti-Fas MoAb at day 3 ( Fig 7A) or day 5 ( Fig 7B) as compared with that obtained after the incubation with control Ab (P < .05). Thus, CD34' cells obtained some Fas Ag expression at day 2; however, susceptibility to Fasmediated cytotoxicity was observed not at day 0 or 2 but at day 3 or 5. At day 2 of culture, Bcl-2 expression was greatly decreased compared with that of day 0. Fas Ag expression on progenitor cells seems to be not enough to mediate apoptosis, and this susceptibility seems to be not thoroughly determined by Bcl-2 expression.
DISCUSSION
The maintenance of hematopoiesis requires continuous proliferation and differentiation of hematopoietic progenitor cells. The regulation of hematopoiesis appears to be mediated through the interaction of progenitor cells with both growth-stimulatory and growth-inhibitory cytokine~.*~-~' In the present study, we did not detect the expression of Fas Ag on freshly isolated CD34' cells, although Bcl-2 was detectable on half of these cells. We also showed that CD34' cells expanded in the presence of hematopoietic growth factors, including SCF, IL-3, IL-6, G-CSF, and Epo, could be induced to express Fas Ag at high levels. These Fas Agpositive cells were inhibited in their ability to form colonies with the clonogenic progenitor assays when treated with agonistic anti-Fas MoAb. However, these CD34' cells ex- ,.. poietic progenitor cells can express Fas Ag. We speculate that the Fas-Fas ligand system is actively involved not only in pathophysiologic state hematopoiesis but also in normal hematopoiesis. Fas ligand is predominantly expressed on activated T cells.'5.'" T cells have an ability to suppress hematopoietic progenitor cells by producing negative hematopoietic regulators such as interferon-y or tumor necrosis factor-a and to kill them by Fas ligand. These findings suggest that T cells may play a role, in part, in the regulation of normal hematopoiesis through the Fas-Fas ligand system.
In clinical settings, it has been reported that hematopoietic progenitor cells. including long-term culture-initiating cells and committed progenitor cells, can be expanded ex vivo, and clinical application of ex vivo expansion of CD34' cells has been investigated."-" A recent clinical trial has shown that peripheral blood CD34' cells expanded ex vivo have a capacity to reconstitute hematopoiesis in patients treated with high-dose chemotherapy?' However, it is unclear whether pluripotent and transplantable stem cells, which retain the capacity for long-term hematopoietic reconstitution, can be expanded ex vivo. The inverse expression of Fas Ag and Bcl-2 on cultured CD34' cells suggests that in vitro expansion of hematopoietic progenitor cells may be a selflimited phenomenon.
In the present study, we showed that the expression of Fas Ag and BcI-2 on hematopoietic progenitor cells may be actively involved in the regulation of proliferation by hematopoietic growth factors. Further study is needed to 
